Creatinine Change on Vasoconstrictors as Mortality Surrogate in Hepatorenal Syndrome: Systematic Review & Meta-Analysis.
Hepatorenal syndrome is a severe complication of cirrhosis and associates with significant mortality. Vasoconstrictor medications improve renal function in patients with hepatorenal syndrome. However, it is unclear to what extent changes in serum creatinine during treatment may act as a surrogate fo...
Main Authors: | Justin M Belcher, Steven G Coca, Chirag R Parikh |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4546623?pdf=render |
Similar Items
-
Vasoconstrictor Therapy for Acute Kidney Injury Hepatorenal Syndrome: A Meta-Analysis of Randomized Studies
by: Ashwani K. Singal, et al.
Published: (2023-01-01) -
Hepatorenal Syndrome
by: Pınar Zeyneloğlu
Published: (2012-04-01) -
HEPATORENAL SYNDROME
by: Matjaž Hafner
Published: (2001-12-01) -
Hepatorenal syndrome
by: Andrés Cárdenas, M.D., et al.
Published: (2003-01-01) -
Hepatorenal syndrome
by: O.I. Taran
Published: (2014-08-01)